Study: Protein IKKa inhibits immune response to bacterial infections
Emergency Management Alert, May 3, 2005
Researchers have identified a protein which is responsible for shutting down the immune response to invading pathogens. Scientists may use this information in the treatment of infections, such as methicillin-resistant Staphylococcus aureus.
The study, which the University of California at San Diego conducted, revealed that when the protein IKKa is inhibited, the human body's response to infection strengthens. IKKa also reduces inflammation.
Scientists studied mice without IKKa and found a significant increased killing of bacteria. However, inflammation was higher than in normal mice. Researchers believe IKKa's role in inflammation can also aid in the future treatment of arthritis.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- Q&A: Coding for dry skin due to cold weather
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- Catch up on what's new with injections and infusions
- Privacy, security concerns high in HIEs
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- Q&A: Coding for sepsis when other conditions are present
- Are your workforce members texting PHI?
- HIPAA Q&A: TPO disclosures to a business associate
- Q&A: Coding for dry skin due to cold weather
- What does case-mix index mean to you?
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Searched
